InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+18.2%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Cavanaugh Stefanie L., Chief Financial Officer. Officer active across 3 companies, notably Apollo Endosurgery, Inc.. Cumulatively, 9 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 7 July 2021. The latest transaction was filed on 4 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
5,937 shares0Common StockSEC:0001641172-25-013811:0
5,938 shares0Common StockSEC:0001641172-25-002184:0
5,937 shares0Common StockSEC:0001688530-25-000001:0
5,938 shares0Common StockSEC:0001688530-24-000002:0
16,804 shares0Common StockSEC:0000950170-24-096254:0
3,268 sharesCommon StockSEC:0001688530-24-000001:0
6,281 shares@ US$3.98100.0% of flowCommon stockSEC:0001688530-23-000002:0
Ideal exit: 19 Apr 2024 (T+270)
28,623 shares0Common StockSEC:0001688530-23-000001:0
91 shares0Common StockSEC:0001251769-21-000092:0
9 of 9 declarations
About Cavanaugh Stefanie L.
Cavanaugh Stefanie L. serves as Chief Financial Officer, Treasurer, and Secretary at Apollo Endosurgery, Inc. She is responsible for the overall financial management of the company, including financial planning and risk management. Stefanie plays a key role in developing financial strategy and communicating financial results. Her expertise in finance is essential for Apollo Endosurgery's growth.
